🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Replimune Group, Inc.

Replimune Group, Inc. logo
Market Cap: Medium
Employees: Medium

RP1

Replimune Group, Inc. develops oncolytic immuno-gene therapies to treat cancer using its proprietary Immunotherapy platform. Its lead product, RP1, is in clinical trials for treating solid tumors.

Tags: RP1, biotechnology, cancer treatment, immunotherapy, oncolytic therapy

Website

Contact | Contact | Careers | Jobs | Jobs | About | About

Symbol: REPL

Recent Price: $12.33

Industry: Biotechnology

CEO: Dr. Sushil Patel Ph.D.

Sector: Healthcare

Employees: 331

Address: 500 Unicorn Park Drive, Woburn, MA 01801

Phone: 781 222 9600

Last updated: 2024-12-31